2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 56.203 | 55.778 | 74.424 | 53.930 | 53.549 | 51.832 | 48.096 | 45.128 | 43.467 | 40.901 |
Total Income - EUR | 56.204 | 55.778 | 74.424 | 53.931 | 70.740 | 51.832 | 50.293 | 55.235 | 63.745 | 40.901 |
Total Expenses - EUR | 67.767 | 71.611 | 72.327 | 66.738 | 67.374 | 66.864 | 57.755 | 53.841 | 57.962 | 65.404 |
Gross Profit/Loss - EUR | -11.563 | -15.833 | 2.097 | -12.807 | 3.366 | -15.032 | -7.463 | 1.394 | 5.783 | -24.503 |
Net Profit/Loss - EUR | -13.249 | -16.950 | 1.353 | -13.369 | 2.657 | -15.551 | -7.944 | 842 | 5.146 | -24.912 |
Employees | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Medistar Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 427 | 105 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 29.807 | 23.496 | 52.563 | 33.372 | 36.533 | 41.386 | 43.228 | 24.539 | 21.518 | 29.874 |
Inventories | 29.317 | 22.680 | 24.216 | 26.147 | 23.590 | 22.970 | 16.969 | 15.706 | 16.589 | 18.215 |
Receivables | 192 | 726 | 27.695 | 2.360 | 3.031 | 6.276 | 6.655 | 4.251 | 4.615 | 6.142 |
Cash | 299 | 90 | 652 | 4.865 | 9.912 | 12.141 | 19.604 | 4.582 | 313 | 5.518 |
Shareholders Funds | -49.788 | -67.153 | -65.116 | -77.362 | -73.816 | -87.937 | -94.214 | -91.282 | -86.420 | -111.070 |
Social Capital | 45 | 45 | 45 | 66 | 64 | 63 | 62 | 61 | 61 | 61 |
Debts | 79.596 | 90.668 | 118.105 | 110.839 | 110.530 | 129.323 | 137.442 | 115.821 | 107.937 | 140.944 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4646 - 4646" | |||||||||
CAEN Financial Year |
4646
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Medistar Srl